{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:20:05Z","timestamp":1790446805913,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672999"],"award-info":[{"award-number":["81672999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nicotinic acetylcholine receptors (nAChRs) have been reported to be overexpressed in malignancies in humans and is associated with tumorigenesis and cell migration. In previous studies of gastric cancer, alpha7 nicotinic acetylcholine receptor (\u03b17-nAChR) overexpression leads to epithelial-mesenchymal transition (EMT) and promotes the migration of gastric cancer cells. Recombinant avirulent LaSota strain of Newcastle disease virus (NDV) expressing the rabies virus glycoprotein (rL-RVG) may promote apoptosis of gastric cancer cells and reduces the migration of lung cancer metastasis. However, whether rL-RVG inhibits migration of gastric cancer cells and what the underlying functional mechanism is remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The gastric cancer cell lines BGC and SGC were randomly divided into 3 groups: rL-RVG, NDV and Phosphate Buffered Solution (PBS) control groups. Furthermore,we adopted ACB and MLA,\u03b17nAChR-siRNA for the overexpression and silencing of \u03b17-nAChR.Corynoxenine was used for inhibiting the MEK-ERK pathway. Western blot, Immunofluoresce,cell proliferation assays,cell migration analyses through wound-healing assays and Transwell assays were used to explore the underlying mechanisms. A mouse xenograft model was used to investigate the effects of rL-RVG,NDV on tumor growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, our findings demonstrate that rL-RVG suppressed the migration of gastric cancer cells and reduced EMT via \u03b17-nAChR in vitro. Furthermore rL-RVG decreased the phosphorylation levels of the MEK\/ERK signaling pathway such as down-regulating the expression of P-MEK and P-ERK. Additionally, rL-RVG also reduced the expression level of mesenchymal markers N-cadherin and Vimentin and enhanced the expression of the epithelial marker E-cadherin. Lastly, rL-RVG inhibited nicotinic acetylcholine receptors (nAChRs) to suppress cell migration and epithelial to mesenchymal transition (EMT) in gastric cell. We also found that rL-RVG suppresses the growth of gastric cancer subcutaneous tumor cells in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>rL-RVG inhibits \u03b17-nAChR-MEK\/ERK-EMT to suppress migration of gastric cancer cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-019-6225-9","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:29:57Z","timestamp":1571790597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating \u03b17-nicotinic acetylcholine receptors\/ERK- EMT"],"prefix":"10.1186","volume":"19","author":[{"given":"Xuefeng","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3666-4103","authenticated-orcid":false,"given":"Yulan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"6","key":"6225_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"6225_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6225_CR3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1684\/bdc.2013.1882","volume":"101","author":"X Jin","year":"2014","unstructured":"Jin X, Zhu Z, Shi Y. Metastasis mechanism and gene\/protein expression in gastric cancer with distant organs metastasis. Bull Cancer. 2014;101(1):E1\u201312.","journal-title":"Bull Cancer"},{"issue":"1","key":"6225_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","volume":"56","author":"NS Millar","year":"2009","unstructured":"Millar NS, Gotti C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology. 2009;56(1):237\u201346.","journal-title":"Neuropharmacology"},{"issue":"8","key":"6225_CR5","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/bjp.2008.185","volume":"154","author":"I Wessler","year":"2008","unstructured":"Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol. 2008;154(8):1558\u201371.","journal-title":"Br J Pharmacol"},{"key":"6225_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000100045","volume":"39","author":"HM Schuller","year":"2007","unstructured":"Schuller HM. Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res. 2007;39:45\u201363.","journal-title":"Prog Exp Tumor Res"},{"issue":"4","key":"6225_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/01.CCM.0000259381.56526.96","volume":"35","author":"VA Pavlov","year":"2007","unstructured":"Pavlov VA, Ochani M, Yang LH, Gallowitsch-Puerta M, Ochani K, Lin X, Levi J, Parrish WR, Rosas-Ballina M, Czura CJ, Larosa GJ, Miller EJ, Tracey KJ, Al-Abed Y. Selective \u03b17-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med. 2007;35(4):1139\u201344.","journal-title":"Crit Care Med"},{"issue":"6","key":"6225_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrc3725","volume":"14","author":"SA Grando","year":"2014","unstructured":"Grando SA. Connections of nicotine to cancer. Nat Rev Cancer. 2014;14(6):419\u201329.","journal-title":"Nat Rev Cancer"},{"key":"6225_CR9","doi-asserted-by":"crossref","unstructured":"Xu J, Liu D, Niu H, Zhu G, Xu Y,Ye D, Li J, Zhang Q. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer. J Exp Clin\u2002Cancer\u2002Res.2017;36(1): 19.","DOI":"10.1186\/s13046-016-0487-8"},{"key":"6225_CR10","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhang J, Yan Y, Cai H, Li M, Sun K, Wang J, Liu X, Wang J, Duan X. Low expression of Rap1GAP is associated with epithelial-mesenchymal transition (EMT) and poor prognosis in gastric cancer. Oncotarget.2017;8(5):8057\u20138068. [11] Carino A, Graziosi L, D'Amore C, Cipriani S, Marchian\u00f2 S, Marino E, Zampella A, Rende M1, Mosci P, Distrutti E, Donini A, Fiorucci S. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget.2016;7(38):61021\u201361035.","DOI":"10.18632\/oncotarget.10477"},{"issue":"9","key":"6225_CR11","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1245\/s10434-011-1598-2","volume":"18","author":"YC Lien","year":"2011","unstructured":"Lien YC, Wang W, Kuo LJ, Liu JJ, Wei PL, Ho YS, Ting WC, Wu CH, Chang YJ. Nicotine promotes cell migration through alpha7 nicotinic acetylcholine receptor in gastric cancer cells. Ann Surg Oncol. 2011;18(9):2671\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"37","key":"6225_CR12","doi-asserted-by":"crossref","first-page":"59199","DOI":"10.18632\/oncotarget.10498","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C, Ding XP, Zhao QN, Yang XJ, An SM, Wang H, Xu L, Zhu L, Chen HZ. Role of \u03b17-nicotinic acetylcholine receptor in nicotine-induced invasion and epithelial-to-mesenchymal transition in human non-small cell lung cancer cells. Oncotarget. 2016;7(37):59199\u2013208.","journal-title":"Oncotarget."},{"issue":"5","key":"6225_CR13","first-page":"924","volume":"6","author":"X Bu","year":"2016","unstructured":"Bu X, Zhao Y, Zhang Z, Wang M, Li M, Yan Y. Recombinant Newcastle disease virus (rL-RVG) triggers autophagy and apoptosis in gastric carcinoma cells by inducing ER stress. Am J Cancer Res. 2016;6(5):924\u201336.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"6225_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12985-017-0852-z","volume":"14","author":"Y Yan","year":"2017","unstructured":"Yan Y, Su C, Hang M, Huang H, Zhao Y, Shao X, Bu X. Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro. Virol J. 2017;14(1):190.","journal-title":"Virol J"},{"key":"6225_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3892\/mmr.2014.2657","volume":"11","author":"Y Yan","year":"2015","unstructured":"Yan Y, Liang B, Zhang J, Liu Y, Bu X. Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro. Mol Med Rep. 2015;11:317\u201326.","journal-title":"Mol Med Rep"},{"key":"6225_CR16","doi-asserted-by":"crossref","unstructured":"Balakrishnan M, George R, Sharma A,Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep.2017;19(8):36. [18] Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol.2018;24(26): 2818\u20132832.","DOI":"10.3748\/wjg.v24.i26.2818"},{"issue":"1","key":"6225_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40169-018-0214-5","volume":"7","author":"CJ LaRocca","year":"2018","unstructured":"LaRocca CJ, Warner SG. Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials. Clin Transl Med. 2018;7(1):35.","journal-title":"Clin Transl Med"},{"key":"6225_CR18","doi-asserted-by":"crossref","unstructured":"Chulpanova D, Solovyeva V, Kitaeva K, Dunham SP, Khaiboullina SF, Rizvanov AA. Recombinant Viruses for Cancer Therapy. Biomedicines.2018;6(4). pii: E94.","DOI":"10.3390\/biomedicines6040094"},{"issue":"9","key":"6225_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/carcin\/bgr090","volume":"32","author":"AM Krais","year":"2011","unstructured":"Krais AM, Hautefeuille AH, Cros MP, Krutovskikh V, Tournier JM, Birembaut P, Th\u00e9pot A, Paliwal A, Herceg Z, Boffetta P, Brennan P, Hainaut PL. CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression. Carcinogenesis. 2011;32(9):1388\u201395.","journal-title":"Carcinogenesis."},{"issue":"S3","key":"6225_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1245\/s10434-011-2064-x","volume":"19","author":"Weu Wang","year":"2011","unstructured":"Wang W, Chin-Sheng H, Kuo L J, Wei PL, Lien YC, Lin FY, Liu HH, Ho YS, Wu CH, Chang YJ. NNK enhances cell migration through \u03b17-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer. Ann Surg Oncol.2012;19 Suppl 3:S580\u2013588.","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"6225_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.intimp.2015.05.033","volume":"29","author":"AI Chernyavsky","year":"2015","unstructured":"Chernyavsky AI, Shchepotin IB, Grando SA. Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors. Int Immunopharmacol. 2015;29(1):36\u201344.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"6225_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pharmthera.2013.10.001","volume":"141","author":"C Neuzillet","year":"2014","unstructured":"Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. MEK in cancer and cancer therapy. Pharmacol Ther. 2014;141(2):160\u201371.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"6225_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41419-018-0877-2","volume":"9","author":"T Li","year":"2018","unstructured":"Li T, Huang H, Shi G, Zhao L, Li T, Zhang Z, Liu R, Hu Y, Liu H, Yu J, Li G. TGF-\u03b21-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition. Cell Death Dis. 2018;9(9):849.","journal-title":"Cell Death Dis"},{"issue":"18","key":"6225_CR24","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","volume":"20","author":"Z Peng","year":"2014","unstructured":"Peng Z, Wang CX, Fang EH, Wang GB, Tong Q. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol. 2014;20(18):5403\u201310.","journal-title":"World J Gastroenterol"},{"key":"6225_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.gene.2018.11.015","volume":"686","author":"K Zhao","year":"2018","unstructured":"Zhao K, He J, Wang Y, Jin SD, Fan Y, Fang N, Qian J, Xu TP, Guo RH. EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression. Gene. 2018;686:118\u201324.","journal-title":"Gene."},{"issue":"4","key":"6225_CR26","first-page":"4592","volume":"15","author":"L Liang","year":"2018","unstructured":"Liang L, Zeng M, Pan H, Liu H, He Y. Nicotinamide N-methyltransferase promotes epithelial-mesenchymal transition in gastric cancer cells by activating transforming growth factor-\u03b21 expression. Oncol Lett. 2018;15(4):4592\u20138.","journal-title":"Oncol Lett"},{"issue":"2","key":"6225_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3892\/ijo.2015.3039","volume":"47","author":"XF Bu","year":"2015","unstructured":"Bu XF, Wang MB, Zhang ZJ, Zhao YH, Li M, Yan YL. Autophagy is involved in recombinant Newcastle disease virus (rL-RVG)-induced cell death of stomach adenocarcinoma cells in vitro. Int J Oncol. 2015;47(2):679\u201389.","journal-title":"Int J Oncol"},{"issue":"6","key":"6225_CR28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600\u20134.","journal-title":"J Recept Signal Transduct Res"},{"key":"6225_CR29","unstructured":"Huo Y N, Chen W, Zheng X X. ROS, MAPK\/ERK and PKC play distinct roles in EGF-stimulated human corneal cell proliferation and migration. Cell\u2002Mol Biol (Noisy-le-grand).2015; 61(7): 6\u201311."},{"issue":"1","key":"6225_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12967-017-1360-z","volume":"15","author":"Z Chen","year":"2017","unstructured":"Chen Z, Liu Z, Huang W, Li Z, Zou J, Wang J, Lin X, Li B, Chen D, Hu Y, Ji J, Gao J, Shen L. Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways. J Transl Med. 2017;15(1):253.","journal-title":"J Transl Med"},{"key":"6225_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2018.09.006","volume":"438","author":"P Yang","year":"2018","unstructured":"Yang P, Su C, Luo X, Zeng H, Zhao L, Wei L, Zhang X, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src\/ERK pathway. Cancer Lett. 2018;438:76\u201385.","journal-title":"Cancer Lett"},{"issue":"1","key":"6225_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbrc.2018.08.155","volume":"504","author":"O Hawsawi","year":"2018","unstructured":"Hawsawi O, Henderson V, Burton LJ, Dougan J, Nagappan P, Odero-Marah V. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer. Biochem Biophys Res Commun. 2018;504(1):196\u2013202.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6225-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T19:21:24Z","timestamp":1603221684000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6225-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6225"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6225-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/497362","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures in this study were approved and reviewed in advance by the Laboratory Animal Management Committee of Jiangsu University and also met the guidelines of the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Ethical written consent of animal experiment was obtained. No ethical approval is required for using any of the cell lines employed for our study reported in this research article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"976"}}